Dorothee Gramatzki

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

Michael Weller, Ruthild G. Weber, Edith Willscher et al. · Acta Neuropathologica · 2015 · 307 citations · Full text

Pathology, High-grade Gliomas, Brain Lesion +18

Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations

Annekathrin Reinhardt, Damian Stichel, Daniel Schrimpf et al. · Acta Neuropathologica · 2018 · 271 citations

Recurrent Mapk Pathway, Neuro-oncology, Glioma +9

Prognostic or predictive value of <i>MGMT</i> promoter methylation in gliomas depends on <i>IDH1</i> mutation

Wolfgang Wick, Christoph Meisner, Bettina Hentschel et al. · Neurology · 2013 · 227 citations · Full text

Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in <i>EGFR</i> -Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors

Jörg Felsberg, Bettina Hentschel, Kerstin Kaulich et al. · Clinical Cancer Research · 2017 · 173 citations

Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling

Guido Reifenberger, Ruthild G. Weber, Vera Riehmer et al. · International Journal of Cancer · 2014 · 146 citations

Engineering, Mgmt Promoter Methylation, Pathology +18